Metairie, LA · Health Care · Form D filed Sep 21, 2026
Therapeutic Neuromodulation Systems LLC raised $1.7M
Therapeutic Neuromodulation Systems LLC is a biotechnology company based in Metairie, Louisiana. In a Form D filed with the SEC on September 21, 2026, it reported raising $1,709,500 from 29 investors as part of an offering of up to $5,000,000. The first sale in the offering took place on October 15, 2017.
- 2nd Form D since 2026. Earlier new notices: Sep 11, 2026. All filings on EDGAR
- Still raising. $3.3M of the $5M offering was still unsold at filing.
$2.7M raised since 2020
2 Form D offerings, as reported to the SEC, the first in Sep 11, 2026. Amendments update a round; they aren't counted twice.
| Filed | Sold | Offering size | Investors |
|---|---|---|---|
| Sep 21, 2026 | $1.7M | $5M | 29 |
| Sep 11, 2026 | $970K | $5M | 33 |
Lead score
31 out of 100
filed recently early raise still raising budget to spend
Outreach kit How it works 1:21
A first message that shows you did your homework, written from this filing. Fill in the brackets and send.
Email · subject: Congrats on the new round
Hi [first name], Congrats on the new round. I saw the raise in your SEC filing. Teams at this stage usually start looking at [what you do] right after a round... [Your name]
LinkedIn note
Congrats on the new round. I work with [who you help] on [what you do] right after a raise. Open to connecting?
Call opener
Hi, this is [your name] from [company]. I am calling because you just filed a raise with the SEC...
Find the right person Founders & CEO · Finance · Operations · People & hiring · Sales & marketing
Track this company How it works 0:56
Saved to your dashboard pipeline, with a badge in Explore.
Loading your outreach kit…
The outreach kit is part of Pro. Copy-ready email, LinkedIn and call openers for every new raise, plus daily alerts for the companies you sell to.
Filing details
- Amount raised
- $1,709,500
- Offering size
- $5,000,000
- Investors so far
- 29
- Minimum investment
- $5,000
- First sale
- October 15, 2017
- Securities offered
- Equity
- Exemption claimed
- Rule 506(b)
- Industry
- Biotechnology
- Headquarters
- Metairie, Louisiana
- Incorporated
- Louisiana
- Entity type
- Limited Liability Company
- Revenue range
- $1 - $1,000,000
Filings
| Filed | Form | Raised | Offering size | Investors | Source |
|---|---|---|---|---|---|
| D (new notice) | $1,709,500 | $5,000,000 | 29 | SEC filing | |
| D (new notice) | $969,500 | $5,000,000 | 33 | SEC filing |
Figures come from the company's own filings with the SEC and are shown as reported. How to read a Form D.
Updated · Raises in the week of Sep 21, 2026 · Raises in Louisiana · September 2026 funding report
Similar raises
Join Re-Femme Inc.
Metairie, LA · filed Aug 27
Re-Femme provides a curated wellness registry for women navigating cancer treatment. Discover chemo essentials, mastectomy recovery products, and create your personalized registry to share with…
First Form DStill raising
Royal & Pelham, Inc.
New Orleans, LA · filed Sep 15First Form DStill raising
Quicktake Health Co.
New Orleans, LA · filed Aug 6
Streamline vital signs measurement with contactless monitoring, automated documentation tools, and hospital kiosks for accurate patient health records.
2nd Form D since 2022
Estuary Biotherapeutics, Inc.
Menlo Park, CA · filed Oct 16First Form DStill raising
North Elam Ambulatory Surgery Center, LLC
Greensboro, NC · filed Oct 16First Form DStill raising
Immorta Bio, Inc.
Miami Beach, FL · filed Oct 162nd Form D since 2026Still raising
Lamina Surgical, Inc.
Oakland, CA · filed Oct 16
Making Open Surgery Safer | Lamina
First Form DStill raising
J3 Bioscience, Inc.
Salt Lake City, UT · filed Oct 1612th Form D since 2012